vs

Side-by-side financial comparison of Doximity, Inc. (DOCS) and Innovex International, Inc. (INVX). Click either name above to swap in a different company.

Innovex International, Inc. is the larger business by last-quarter revenue ($273.6M vs $185.1M, roughly 1.5× Doximity, Inc.). Doximity, Inc. runs the higher net margin — 33.3% vs 5.1%, a 28.2% gap on every dollar of revenue. On growth, Doximity, Inc. posted the faster year-over-year revenue change (9.8% vs 9.1%). Over the past eight quarters, Innovex International, Inc.'s revenue compounded faster (46.2% CAGR vs 25.2%).

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

DOCS vs INVX — Head-to-Head

Bigger by revenue
INVX
INVX
1.5× larger
INVX
$273.6M
$185.1M
DOCS
Growing faster (revenue YoY)
DOCS
DOCS
+0.6% gap
DOCS
9.8%
9.1%
INVX
Higher net margin
DOCS
DOCS
28.2% more per $
DOCS
33.3%
5.1%
INVX
Faster 2-yr revenue CAGR
INVX
INVX
Annualised
INVX
46.2%
25.2%
DOCS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
DOCS
DOCS
INVX
INVX
Revenue
$185.1M
$273.6M
Net Profit
$61.6M
$14.0M
Gross Margin
89.9%
28.9%
Operating Margin
38.9%
9.4%
Net Margin
33.3%
5.1%
Revenue YoY
9.8%
9.1%
Net Profit YoY
-18.1%
-56.1%
EPS (diluted)
$0.31
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOCS
DOCS
INVX
INVX
Q4 25
$185.1M
$273.6M
Q3 25
$168.5M
$240.0M
Q2 25
$145.9M
$224.2M
Q1 25
$138.3M
$240.4M
Q4 24
$168.6M
$250.7M
Q3 24
$136.8M
$151.8M
Q2 24
$126.7M
$130.3M
Q1 24
$118.1M
$128.0M
Net Profit
DOCS
DOCS
INVX
INVX
Q4 25
$61.6M
$14.0M
Q3 25
$62.1M
$39.2M
Q2 25
$53.3M
$15.3M
Q1 25
$62.5M
$14.8M
Q4 24
$75.2M
$31.8M
Q3 24
$44.2M
$82.6M
Q2 24
$41.4M
$9.5M
Q1 24
$40.6M
$16.4M
Gross Margin
DOCS
DOCS
INVX
INVX
Q4 25
89.9%
28.9%
Q3 25
90.3%
31.6%
Q2 25
89.2%
32.0%
Q1 25
89.5%
31.8%
Q4 24
91.6%
33.9%
Q3 24
90.0%
34.7%
Q2 24
89.3%
35.3%
Q1 24
89.4%
38.4%
Operating Margin
DOCS
DOCS
INVX
INVX
Q4 25
38.9%
9.4%
Q3 25
37.8%
26.0%
Q2 25
37.4%
10.1%
Q1 25
35.2%
9.1%
Q4 24
47.4%
10.7%
Q3 24
38.8%
-8.7%
Q2 24
36.4%
10.0%
Q1 24
35.5%
17.4%
Net Margin
DOCS
DOCS
INVX
INVX
Q4 25
33.3%
5.1%
Q3 25
36.8%
16.3%
Q2 25
36.5%
6.8%
Q1 25
45.2%
6.1%
Q4 24
44.6%
12.7%
Q3 24
32.3%
54.4%
Q2 24
32.7%
7.3%
Q1 24
34.4%
12.8%
EPS (diluted)
DOCS
DOCS
INVX
INVX
Q4 25
$0.31
$0.20
Q3 25
$0.31
$0.57
Q2 25
$0.27
$0.22
Q1 25
$0.31
$0.21
Q4 24
$0.37
$-0.03
Q3 24
$0.22
$1.99
Q2 24
$0.21
$0.30
Q1 24
$0.20
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOCS
DOCS
INVX
INVX
Cash + ST InvestmentsLiquidity on hand
$64.8M
Total DebtLower is stronger
$18.9M
Stockholders' EquityBook value
$979.3M
$1.1B
Total Assets
$1.2B
$1.3B
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOCS
DOCS
INVX
INVX
Q4 25
$64.8M
Q3 25
$169.2M
Q2 25
$137.3M
Q1 25
$209.6M
Q4 24
$165.3M
Q3 24
$184.2M
Q2 24
$111.4M
$185.6M
Q1 24
$96.8M
$202.2M
Total Debt
DOCS
DOCS
INVX
INVX
Q4 25
$18.9M
Q3 25
$20.1M
Q2 25
$34.8M
Q1 25
$19.7M
Q4 24
$24.9M
Q3 24
$12.4M
Q2 24
Q1 24
Stockholders' Equity
DOCS
DOCS
INVX
INVX
Q4 25
$979.3M
$1.1B
Q3 25
$1.1B
$1.0B
Q2 25
$1.0B
$995.6M
Q1 25
$1.1B
$978.4M
Q4 24
$1.0B
$958.2M
Q3 24
$961.2M
$904.4M
Q2 24
$913.6M
$352.5M
Q1 24
$901.4M
$344.3M
Total Assets
DOCS
DOCS
INVX
INVX
Q4 25
$1.2B
$1.3B
Q3 25
$1.3B
$1.3B
Q2 25
$1.2B
$1.2B
Q1 25
$1.3B
$1.2B
Q4 24
$1.2B
$1.2B
Q3 24
$1.1B
$1.1B
Q2 24
$1.1B
$1.0B
Q1 24
$1.1B
$1.0B
Debt / Equity
DOCS
DOCS
INVX
INVX
Q4 25
0.02×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.02×
Q4 24
0.03×
Q3 24
0.01×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOCS
DOCS
INVX
INVX
Operating Cash FlowLast quarter
$60.9M
$52.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.99×
3.74×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOCS
DOCS
INVX
INVX
Q4 25
$60.9M
$52.2M
Q3 25
$93.9M
$48.4M
Q2 25
$62.1M
$59.2M
Q1 25
$98.5M
$31.1M
Q4 24
$65.2M
$36.3M
Q3 24
$68.3M
$21.7M
Q2 24
$41.2M
$22.8M
Q1 24
$63.9M
$12.6M
Free Cash Flow
DOCS
DOCS
INVX
INVX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$16.6M
Q1 24
$7.8M
FCF Margin
DOCS
DOCS
INVX
INVX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
12.7%
Q1 24
6.1%
Capex Intensity
DOCS
DOCS
INVX
INVX
Q4 25
Q3 25
Q2 25
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
4.7%
Q1 24
0.0%
3.7%
Cash Conversion
DOCS
DOCS
INVX
INVX
Q4 25
0.99×
3.74×
Q3 25
1.51×
1.23×
Q2 25
1.16×
3.86×
Q1 25
1.58×
2.11×
Q4 24
0.87×
1.14×
Q3 24
1.55×
0.26×
Q2 24
1.00×
2.39×
Q1 24
1.57×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOCS
DOCS

Subscription$175.4M95%
Service Other$9.7M5%

INVX
INVX

Products$202.7M74%
Leasing$42.3M15%
Services$28.6M10%

Related Comparisons